1.

Ann Intern Med. 1993 Apr1;118(7):495-503.

Fluconazole prophylaxis offungal infections in patients with acute leukemia. Results of a randomizedplacebo-controlled, double-blind, multicenter trial.

WinstonDJ, ChandrasekarPH, LazarusHM, GoodmanJL, SilberJL, HorowitzH, ShadduckRK, RosenfeldCS, HoWG, IslamMZ, BuellDN.

2.

J Infect Dis. 1995Oct;172(4):1035-41.

Effect of prophylacticfluconazole on the frequency of fungal infections, amphotericin B use, andhealth care costs in patients undergoing intensive chemotherapy for hematologicneoplasias.

SchaffnerA, SchaffnerM.

3.

J Infect Dis. 1995Jun;171(6):1545-52.

Efficacy and safety offluconazole prophylaxis for fungal infections after marrow transplantation--aprospective, randomized, double-blind study.

SlavinMA, OsborneB, AdamsR, LevensteinMJ, SchochHG, FeldmanAR, MeyersJD, BowdenRA.

4.

Leuk Lymphoma. 1993Nov;11(5-6):353-8.  (WE MIGTH WANT TO EXCLUDE THIS ONE BEC IT IS ITRACONAZOLE WITHAmB-PO, OTHERWISE WE ALSO NEED TO INCLUDE KERN STUDY)

Efficacy of itraconazole inthe prevention of fungal infections among neutropenic patients with hematologicmalignancies and intensive chemotherapy. A double blind, placebo controlledstudy.

VreugdenhilG, VanDijke BJ, DonnellyJP, NovakovaIR, RaemaekersJM, Hoogkamp-KorstanjeMA, KosterM, dePauw BE.

Trial dataset